These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 17493386)
41. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. Jing Z; Nan KJ; Hu ML World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979 [TBL] [Abstract][Full Text] [Related]
42. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma]. Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878 [TBL] [Abstract][Full Text] [Related]
43. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma. Shehata MA; Nosseir HR; Nagy HM; Farouk G Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156 [TBL] [Abstract][Full Text] [Related]
44. [Expression of caspase3 gene does not correlate with tumor cell apoptosis in primary hepatocellular carcinoma]. Sun B; Zhang J; Wang B Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):39-41. PubMed ID: 11776594 [TBL] [Abstract][Full Text] [Related]
45. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Lu Y; Wu LQ; Li CS; Wang SG; Han B Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854 [TBL] [Abstract][Full Text] [Related]
46. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma. Fujioka M; Nakashima Y; Nakashima O; Kojiro M Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002 [TBL] [Abstract][Full Text] [Related]
47. Clinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomas. Zhou J; Song SD; Li DC; Zhou J; Zhu DM; Zheng SY Asian Pac J Cancer Prev; 2012; 13(2):719-24. PubMed ID: 22524850 [TBL] [Abstract][Full Text] [Related]
48. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells. Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031 [TBL] [Abstract][Full Text] [Related]
49. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis]. Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481 [TBL] [Abstract][Full Text] [Related]
50. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis. Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221 [TBL] [Abstract][Full Text] [Related]
51. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma. Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948 [TBL] [Abstract][Full Text] [Related]
52. Expression and possible role of ets-1 in hepatocellular carcinoma. Ito Y; Miyoshi E; Takeda T; Sakon M; Noda K; Tsujimoto M; Monden M; Taniguchi N; Matsuura N Am J Clin Pathol; 2000 Nov; 114(5):719-25. PubMed ID: 11068545 [TBL] [Abstract][Full Text] [Related]
53. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma. Kalogeraki A; Garbagnati F; Santinami M; Zoras O Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598 [TBL] [Abstract][Full Text] [Related]
54. Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma. Ji Y; Li B; Zhu Z; Guo X; He W; Fan Z; Zhang W Biomed Pharmacother; 2015 Feb; 69():409-15. PubMed ID: 25661390 [TBL] [Abstract][Full Text] [Related]
55. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma. Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586 [TBL] [Abstract][Full Text] [Related]
56. AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. Kwon JH; Ahn KS; Moon YH; Park JY; Wang HJ; Choi KY; Kim G; Joh JW; Lee KG; Kang KJ J Korean Med Sci; 2015 Sep; 30(9):1253-9. PubMed ID: 26339164 [TBL] [Abstract][Full Text] [Related]
57. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805 [TBL] [Abstract][Full Text] [Related]
58. Functional characterisation of decoy receptor 3 in Crohn's disease. Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087 [TBL] [Abstract][Full Text] [Related]
59. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087 [TBL] [Abstract][Full Text] [Related]
60. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues. Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]